Silencing of APE1 enhances sensitivity of human hepatocellular carcinoma cells to radiotherapy in vitro and in a xenograft model.

Silencing of APE1 enhances sensitivity of human hepatocellular carcinoma cells to radiotherapy in vitro and in a xenograft model.

Item
http://www.wikidata.org/entity/Q34589542
Involvement of DNA damage response pathways in hepatocellular carcinoma.Identification of a novel potential antitumor activity of gossypol as an APE1/Ref-1 inhibitor.APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functionsFunctional analysis of tanshinone IIA that blocks the redox function of human apurinic/apyrimidinic endonuclease 1/redox factor-1.Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells.Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.Transcriptional Up-Regulation of APE1/Ref-1 in Hepatic Tumor: Role in Hepatocytes Resistance to Oxidative Stress and Apoptosis.Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients.Human apurinic/apyrimidinic endonuclease 1.Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysisResistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.GADD45α sensitizes cervical cancer cells to radiotherapy via increasing cytoplasmic APE1 level.The regulatory role of APE1 in epithelial-to-mesenchymal transition and in determining EGFR-TKI responsiveness in non-small-cell lung cancer
P2860

Silencing of APE1 enhances sensitivity of human hepatocellular carcinoma cells to radiotherapy in vitro and in a xenograft model.

Item
http://www.wikidata.org/entity/Q34589542
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@ast
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@en
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@nl
type
label
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@ast
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@en
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@nl
prefLabel
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@ast
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@en
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Silencing of APE1 enhances sen ...... itro and in a xenograft model.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0055313
P407
P433
P478
P577
P5875
P698
P921
P932